Diagnose Parkinson using ocular microtremor
- Trial ID
- NCT06051877
- Official Title
- Ocular Microtremor in Parkinson's Disease
- Goal
- Diagnose Parkinson using ocular microtremor
- Status
- RECRUITING
- Sponsor
- Northumbria University
- Study Type
- OBSERVATIONAL
- Enrollment
- 40 participants
- Conditions
- Parkinson's Disease, Parkinson Disease
Plain-Language Summary
The goal is to see whether ocular microtremor, a tiny involuntary eye jitter, can serve as an objective sign to detect or monitor Parkinson's disease. Researchers will noninvasively record these very small, constant eye movements that reflect brainstem motor activity and compare patterns in people with suspected or confirmed Parkinson's to healthy controls. There is no drug or therapy to take part in, measurements are taken alongside usual care and should not interfere with existing Parkinson's treatments. The study is enrolling about 40 adults aged 18 and older, including people with suspected or confirmed Parkinson's and healthy controls, but it excludes those with prior head injury, ocular disease like cataracts, significant psychiatric conditions, or dementia (MoCA score under 21).
Locations
- Gateshead Health NHS Foundation Trust, Gateshead, Tyne and Wear, United Kingdom
- Northumbria Healthcare NHS Trust, North Shields, Tyne and Wear, United Kingdom
Frequently Asked Questions
- What is this trial testing?
- This trial is studying an experimental treatment. The goal is to see whether ocular microtremor, a tiny involuntary eye jitter, can serve as an objective sign to detect or monitor Parkinson's disease. Researchers will noninvasively record these very small, constant eye movements that reflect brainstem motor activity and compare patterns in people with suspected or confirmed Parkinson's to healthy controls. There is no drug or therapy to take part in, measurements are taken alongside usual care and should not interfere with existing Parkinson's treatments. The study is enrolling about 40 adults aged 18 and older, including people with suspected or confirmed Parkinson's and healthy controls, but it excludes those with prior head injury, ocular disease like cataracts, significant psychiatric conditions, or dementia (MoCA score under 21).
- Who can participate?
- Participants must be at least 18 Years.
- Where is this trial located?
- This trial is recruiting at 2 locations.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 1 month.